Comparative Study of Barnidipine and Felodipine in Chinese Patients with Essential Hypertension

Abstract

This study evaluated the efficacy and safety of barnidipine for the treatment of mild-to-moderate essential hypertension in Chinese patients. A total of 131 patients were randomized to receive either barnidipine (10-15 mg) or felodipine (5-10 mg) once daily for 4 weeks. Both drugs reduced blood pressure significantly, with ≥ 87% of patients obtaining a marked or moderate effect. The mean ± SD reductions in systolic and diastolic blood pressure were 19.2 ± 13.6 and 14.4 ± 7.0 mmHg, respectively, for barnidipine treatment, and 20.3 ± 11.3 and 14.7 ± 7.7 mmHg, respectively, for felodipine treatment. There were no significant differences between the two drugs in terms of anti-hypertensive effect, heart rate, laboratory test results or incidence of adverse events. More patients taking felodipine experienced palpitations, but this difference was not statistically significant. Barnidipine is as efficacious and safe as felodipine in the treatment of essential hypertension in Chinese patients.